The Firm represented J.P. Morgan Securities LLC, Itau BBA USA Securities, Inc., BTG Pactual US Capital, LLC, UBS Securities LLC, BofA Securities, Inc., Bradesco Securities Inc. and Safra Securities LLC, as placement agents, in connection with the initial public offering in Brazil of 94,225,918 common shares of CM Hospitalar S.A. (“Viveo”) on the São Paulo Stock Exchange (B3). The offering consisted of a primary offering of 35,140,562 common shares and a secondary offering of 59,085,356 common shares, at a price per share of R$19.92, and raised an aggregate of approximately R$1.9 billion.
The common shares were offered to qualified institutional buyers in the United States under Rule 144A and to non-U.S. persons in reliance on Regulation S. The common shares of Viveo began trading on the B3 under the ticker symbol “VVEO3” on August 9, 2021.
Viveo is an one-stop-shop ecosystem of healthcare products and services which offers agile, reliable and innovative B2B and B2C healthcare solutions, including the production and distribution of medicines, medical and hospital products and vaccines and logistical solutions. Viveo has approximately 4.4 thousand employees and its customers include hospitals, clinics, laboratories and direct patients located mainly in Brazil, but also in other countries in Latin America, Europe and Africa.
The Simpson Thacher team was led by Grenfel S. Calheiros and Paulo F. Cardoso and included Isabel de Carvalho and Fabiano Maia (Capital Markets); and Jonathan Cantor and Scott Grundei (Tax).